Infliximab in Treating Patients With Myelodysplastic Syndrome
Clinical trial NCT00074074 · COMPLETED
Trial details
- NCT number
- NCT00074074
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2006-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.